Mixing two different COVID-19 vaccines gives a better immune response?

▴ Mixing two different COVID-19 vaccines gives a better immune response?
Different studies are being carried out worldwide to understand if a combination of two different vaccines can outperform two doses of the same vaccines

The DGCI has given permission to conduct a trial study of mixed doses of Covaxin and Covishield. The study will get conducted by Christian Medical College (CMC) Vellore and will include 300 trial participants. The two vaccine uses different platforms: Covishield is an adenovirus vector platform-based vaccine, while Covaxin is an inactivated whole virus vaccine.

Earlier this year, in May, 18 villagers of district Siddharth Nagar, Uttar Pradesh had got Covishield as the first vaccine dose and Covaxin as the second dose mistakenly. This was not done purposely. The study compares the vaccine response of these 18 villagers with 40 recipients of two doses of Covishield and 40 recipients of two doses of Covaxin. The study illustrates that a combination of (heterologous) different vaccines shows a better immune response than the two doses of the same (homologous) vaccine. 

According to the World Health Organization, there is currently limited data on the immunogenicity or efficacy of a “mix and match” regimen. WHO said, “mix-and-match regimens are likely to work. However, we need to analyze the evidence in each of these vaccine combinations before any other recommendations can be made.”

Before Covid-19, studies have shown better and broader immune responses with the mixing of vaccines of different types. Such heterologous strategies are being studied in HIV, malaria, flavivirus (e.g. dengue), HPV, Ebola, and influenza. 

The idea of heterologous boosting initially emerged in Europe, when the AstraZeneca vaccine was found to be associated with blood clotting in a handful of individuals. A second dose with a different platform vaccine was recommended.

Tags : #Spotlight #Covishield #Covaxin #Mixedvaccination #DGCI #WHO #Latestnewsonvaccine #SmitaKumar #Medicircle

Related Stories

Loading Please wait...


Trending Now

Why are key populations on the blindspot in the global HIV response?July 20, 2024
Exploring the Link Between Tinnitus and Body Composition: What Recent Research RevealsJuly 20, 2024
Surge in Brain Infections in India During Monsoon: A Growing ConcernJuly 20, 2024
We have more infection-prevention options now but are they actual choices for the people?July 19, 2024
New humidity-driven membrane to remove carbon dioxide from the airJuly 19, 2024
Introducing the World's First Consent-Based Data-Sharing Framework Built on Open Standards: The Affinidi Iota Framework July 19, 2024
The Power of Green Spaces: Evidence That Parks May Delay Cognitive DeclineJuly 19, 2024
Strengthening Healthcare in India: The Push for Better Coverage with Ayushman BharatJuly 19, 2024
SARV Events & Celebrations Shines at "Edu-Bizz Leadership Summit & Awards 24July 18, 2024
UAE launches global initiative to build 10 hospitals to address critical healthcare gaps as part of Zayed Humanitarian Legacy InitiativeJuly 18, 2024
Geetanjali Homestate Expands Global Presence with the Launch of Geetanjali GlobalJuly 18, 2024
Changes projected in marine fish communities due to climate changeJuly 18, 2024
Understanding the Chandipura Virus Outbreak in Gujarat: A Critical OverviewJuly 18, 2024
Landmark Study Links Severe Endometriosis to Increased Risk of Ovarian CancerJuly 18, 2024
Equipping Healthcare Professionals for Global Opportunities: GIMS Partners with NSDCJuly 18, 2024
Hormone Modulating Therapy for Breast Cancer and Its Link to Lower Alzheimer’s RiskJuly 18, 2024
Multipl Secures $1.5 Million in Additional Funds, Led by Blume Ventures and MIXI Global Investments, JapanJuly 17, 2024
FedEx to empower youth with digital skilling programJuly 17, 2024
Putting people first means following Gandhi's TalismanJuly 17, 2024
American Oncology Institute (AOI) Launches #BreaktheHabit Campaign to Raise Awareness on Head & Neck cancerJuly 17, 2024